Assessment of Major Adverse Cardiovascular Event Across Diverse Racial Groups of Psoriasis Patients on Biologic Therapy: A Retrospective Cohort Study Article

publication date

  • July 26, 2026

webpage

published in

keywords

  • biologics
  • cardiovascular
  • comparative effectiveness
  • interleukin 12/23 inhibitor
  • interleukin 17 inhibitor
  • interleukin 23 inhibitor
  • psoriasis
  • tnf inhibitor